Top Professor apparently canceled for his Research on Tylenol that wasn’t helpful for Duke University’s Cash Flow or for Big Pharma
An immunologist and biochemist, William Parker, Ph.D., was apparently driven from his 28-year position at Duke University for his research on Tylenol.
An email trail The Epoch Times obtained from the Duke Department of Surgery administration showed that Dr. Parker was forced to leave the school because his research showed that Tylenol can cause some serious problems.
Tylenol’s maker Johnson & Johnson, had “gifted” or “granted” Duke millions of dollars for “research” through the years. When the biochemist’s research not only failed to help J&J promote Tylenol, but also showed that acetaminophen in Tylenol could potentially cause autism, Parker’s days were numbered.
Related: Duke Whistleblower gets $33M+ in Research Fraud Settlement
Duke informed Dr. Parker in January 2021 (when he was just 55) that the school administration would not be renewing his contract after his nearly three decades of service.
Dr. Parker achieved a measure of fame as a member of a research team which discovered the function of the appendix. The team found it harbored beneficial bacteria.
He worked with different surgeons through the years, searching through transplanted tissue for immune markers. He also trained undergraduates and medical school students in the scientific method. He taught students how to set up experiments.
Despite a fantastic record as both an instructor and a scientist, Parker was forced to retire because his ongoing research on acetaminophen was potentially disastrous for J&J profits.
Duke says: “Not in Their Strategic Best Interest”’
Since Parker’s research had led to a threat of losing his research funding, he found a private donor who was willing to support both his salary and future research costs. That donor was willing to support his work for at least a year or more.
Nevertheless, when Parker told Duke administrators he had gotten his own funding to keep his lab open and continue some vital work, Duke said it wouldn’t accept the funds he had secured.
Kent J. Weinhold, Division of Surgical Sciences Chief, a professor of immunology and a professor in pathology, wrote in an email to Parker on April 5, 2021: “Evidently, donations can be received to support research initiatives that are strategically aligned with the institution, and can be used at the discretion of the beneficiary.”
“They cannot be tied directly to a salary line or specific experiments, as such would be regarded a grant, not a gift. So a donor can donate to your laboratory, but cannot donate money specifically for your salary. The real issue here is perhaps more direct. To receive a donation for you, it would require that the Department strategically wants to keep your lab open. Unfortunately, the Department feels that is not in their strategic best interest to keep your lab open. With this being the case, receipt of a donation would not be possible.”
Dr. Parker told The Epoch Times that, in his experience, Duke’s shutting down his lab in these circumstances, where a researcher had actually secured funding, was unprecedented.
Duke dismisses a Successful Scientific Legacy
Professor Parker has published nearly 200 papers. Many contain discoveries on a level that only the most prestigious scientists at other institutions have accomplished. Besides discovering the human appendix’s function as a safe place for the body to hold beneficial bacteria, he was a pioneer in the evaluation of immune systems of wild animals.
At the cutting edge of immune system research for years, Parker recently researched the benefits of intestinal worms that may help the human immune system and even help with depression and anxiety.
Was Parker ousted for His Research? Does any other conclusion make sense?
Since Parker was such a successful and well-published academic conducting cutting-edge research, why did Duke decide that it was “not in their strategic best interests” to keep his lab open? Parker told the Epoch Times that no one at Duke gave him a clear answer to that question. But he also said that he had begun noticing a lack of institutional support beginning in 2017.
It was that year in which he and a team of scientists, including a well-known brain researcher in the Department of Neurology at Harvard Medical School, published a review article in the Journal of International Medical Research. The review explored the scientific literature that linked Tylenol’s main ingredient — acetaminophen — to oxidative stress, inflammation, autism.
Duke had supported his previous research, but with acetaminophen, even though Parker held the needed research funding in his academic account, Duke refused to pay the journal’s publication fee.
Parker told The Epoch Times he doesn’t know whether his work on acetaminophen caused the closing of his lab, but he said, “I don’t have another reasonable explanation.”
Tylenol Toxic for Children
Dr. Parker also told The Epoch Times that one of his most important research projects uncovered toxic effects of acetaminophen, particularly for infants and children. He alleges scientific evidence overwhelmingly indicates early exposure to acetaminophen causes autism.
Tylenol Acetaminophen most common
Tylenol is the most common brand name of acetaminophen in the United States. A J&J web site shows ten different Tylenol products marketed for children, with two for infants. According to one report, the global market for acetaminophen was valued at $9.44 billion in 2021.
Despite research which shows it toxic to the brain and immune system, many medical doctors continue to recommend Tylenol for kids. Some remain unaware of the 2009 research which showed that ingesting acetaminophen before or after childhood vaccinations negatively affects the body’s immune response.
RELATED
